In patients with diabetes, myocardial fibrosis may contribute to the pathogenesis of heart
failure and arrhythmogenesis, increasing ventricular stiffness and delaying conduction …

Cardiometabolic diseases (CMDs) are metabolic diseases (eg, obesity, diabetes,
atherosclerosis, rare genetic metabolic diseases, etc.) associated with cardiac pathologies …

High dietary intake of dietary polyphenols is associated with a decreased risk of chronic
diseases, especially in inflammation. However, mechanisms responsible for their anti …

Green tea and its active extracts have been widely used in a variety of dietary supplements.
However, to date, the interaction of these bioactive compounds in green tea and their protein …

Cardiovascular diseases are the leading cause of death in people with diabetes. Diabetic
cardiomyopathy (DC) is an important complication of diabetes and represents a distinct …

Protein phosphorylation is an important link in a variety of signaling pathways, and most of
the important life processes in cells involve protein phosphorylation. Based on the amino …

Diabetes mellitus is a metabolic disorder denoted by chronic hyperglycemia that drives
maladaptive structural changes and functional damage to the vasculature. Attenuation of this …

Cardiovascular diseases (CVDs) are the main diseases that endanger human health, and
their risk factors contribute to high morbidity and a high rate of hospitalization. Cell death is …

Peroxisome proliferator‐activated receptors (PPARs) are members of the ligand‐dependent
nuclear receptor family. PPARs have attracted wide attention as pharmacologic mediators to …

The prevalence of diabetic cardiomyopathy (DCM), a specific cardiovascular complication of
diabetes mellitus, has recently increased. Its pathogenesis is not fully understood, and no …